Skip to main content

Advertisement

Log in

Hypertension in pregnancy as a risk factor for placenta accreta spectrum: a systematic review incorporating a network meta-analysis

  • Review
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Background

A meta-analysis was performed to evaluate the potential effects of hypertension in pregnancy on the placenta accreta spectrum.

Methods

A systematic literature search in OVID, Embase, Cochrane Library, PubMed, and Google Scholar up to May 2021 was done, and six studies were found including 126,224 pregnant women; 7164 of them had hypertension in pregnancy and 816 had placenta accreta spectrum. They were reporting relationships between the potential effects of hypertension in pregnancy on the placenta accreta spectrum. The odds ratio (OR) with 95% confidence intervals (CIs) was calculated to assess the potential effects of hypertension in pregnancy on the placenta accreta spectrum using the dichotomous with a random- or fixed-effect model.

Results

Pregnancy-induced hypertension was significantly related to lower prevalence of placenta accreta spectrum (OR 0.56; 95% CI 0.37–0.84, p = 0.005) with no heterogeneity (I2 = 0%) compared to control (no hypertension in pregnancy). When looking at the result comparing the prevalence of hypertension in pregnancy in women with placenta accrete compared to control (no placenta accrete), we found that the placenta accreta spectrum was significantly related to lower prevalence of hypertension in pregnancy (OR 0.65; 95% CI 0.43–0.98, p = 0.04) compared to control.

Conclusions

Hypertension in pregnancy may have a lower prevalence of placenta accrete. Further studies are required to validate these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dreux S et al (2012) Second-trimester maternal serum markers and placenta accreta. Prenat Diagn 32(10):1010–1012

    Article  CAS  PubMed  Google Scholar 

  2. Garmi G, Salim R (2012) Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet Gynecol Int 2012:1

    Article  Google Scholar 

  3. Yang Y-Y et al (2018) A retrospective cohort study of risk factors and pregnancy outcomes in 14,014 Chinese pregnant women. Medicine 97(33):e11748

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ishibashi H et al (2017) Cervical varicosities may predict placenta accreta in posterior placenta previa: a magnetic resonance imaging study. Arch Gynecol Obstet 296(4):731–736

    Article  CAS  PubMed  Google Scholar 

  5. Matsubara S (2012) Uterine incision for anterior placenta previa without placenta accreta. Arch Gynecol Obstet 285(2):557–558

    Article  PubMed  Google Scholar 

  6. Orbach A et al (2011) Peripartum cesarean hysterectomy: critical analysis of risk factors and trends over the years. J Matern Fetal Neonatal Med 24(3):480–484

    Article  PubMed  Google Scholar 

  7. Korejo R et al (2012) Emergency obstetric hysterectomy. J Pak Med Assoc 62(12):1322–1325

    PubMed  Google Scholar 

  8. Wu S, Kocherginsky M, Hibbard JU (2005) Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 192(5):1458–1461

    Article  PubMed  Google Scholar 

  9. Khong T et al (1998) Pregnancies complicated by retained placenta: sex ratio and relation to pre-eclampsia. Placenta 19(8):577–580

    Article  CAS  PubMed  Google Scholar 

  10. Gielchinsky Y et al (2002) Placenta accreta—summary of 10 years: a survey of 310 cases. Placenta 23(2–3):210–214

    Article  CAS  PubMed  Google Scholar 

  11. Usta IM et al (2005) Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol 193(3):1045–1049

    Article  PubMed  Google Scholar 

  12. Fitzpatrick KE et al (2012) Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS ONE 7(12):e52893

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Bowman ZS et al (2014) Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol 31(09):799–804

    PubMed  Google Scholar 

  14. Eshkoli T et al (2013) Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol 208(3):219.e1-219.e7

    Article  PubMed  Google Scholar 

  15. Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012

    Article  CAS  PubMed  Google Scholar 

  16. Higgins JP et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  PubMed Central  Google Scholar 

  17. Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34

    Article  PubMed  Google Scholar 

  18. Gupta A et al (2018) Obesity is independently associated with increased risk of hepatocellular cancer–related mortality. Am J Clin Oncol 41(9):874–881

    Article  PubMed  PubMed Central  Google Scholar 

  19. Collaboration C (2020) RoB 2: A revised Cochrane risk-of-bias tool for randomized trials.. bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. Accessed 6 Dec 2019

  20. Hung T-H et al (1999) Risk factors for placenta accreta. Obstet Gynecol 93(4):545–550

    CAS  PubMed  Google Scholar 

  21. Sheiner E et al (2001) Placenta previa: obstetric risk factors and pregnancy outcome. J Matern Fetal Med 10(6):414–419

    Article  CAS  PubMed  Google Scholar 

  22. Usta IM et al (2005) Placenta previa-accreta: Risk factors and complications. Am J Obstet Gynecol 193(3, Supplement):1045–1049

    Article  PubMed  Google Scholar 

  23. Alves E et al (2013) Impact of risk factors on hypertensive disorders in pregnancy, in primiparae and multiparae. Ann Hum Biol 40(5):377–384

    Article  PubMed  Google Scholar 

  24. Lindheimer MD, Taler SJ, Cunningham FG (2008) Hypertension in pregnancy. J Am Soc Hypertens 2(6):484–494

    Article  PubMed  Google Scholar 

  25. Kuklina EV, Ayala C, Callaghan WM (2009) Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 113(6):1299–1306

    Article  PubMed  Google Scholar 

  26. Tantbirojn P, Crum C, Parast M (2008) Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta 29(7):639–645

    Article  CAS  PubMed  Google Scholar 

  27. Fan D et al (2017) Prevalence of abnormally invasive placenta among deliveries in mainland China: A PRISMA-compliant systematic review and meta-analysis. Medicine 96(16):e6636

    Article  PubMed  PubMed Central  Google Scholar 

  28. Basta P et al (2010) The frequency of CD25+ CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua. Reprod Biol Endocrinol 8(1):1–7

    Article  Google Scholar 

  29. Schwede S, Alfer J, Von Rango U (2014) Differences in regulatory T-cell and dendritic cell pattern in decidual tissue of placenta accreta/increta cases. Placenta 35(6):378–385

    Article  CAS  PubMed  Google Scholar 

  30. Yliniemi A et al (2015) Combination of PAPPA, fhCGβ, AFP, PIGF, sTNFR1, and maternal characteristics in prediction of early-onset preeclampsia. Clin Med Insights: Reprod Health 9:CMRH.S21865

    Google Scholar 

  31. Desai N et al (2014) Elevated first trimester PAPP-A is associated with increased risk of placenta accreta. Prenat Diagn 34(2):159–162

    Article  CAS  PubMed  Google Scholar 

  32. Lash GE, Ernerudh J (2015) Decidual cytokines and pregnancy complications: focus on spontaneous miscarriage. J Reprod Immunol 108:83–89

    Article  CAS  PubMed  Google Scholar 

  33. Feldman DR et al (2009) Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma. J Clin Oncol 27(9):1432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. McMahon K et al (2014) Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta. Am J Obstet Gynecol 210(1):68.e1-68.e4

    Article  CAS  PubMed  Google Scholar 

  35. Wang W et al (2018) Association between hypertensive disorders complicating pregnancy and risk of placenta accreta: a meta-analysis and systematic review. Hypertens Pregnancy 37(3):168–174

    Article  CAS  PubMed  Google Scholar 

  36. Moustafa IO et al (2017) Clinical outcome associated with the use of different inhalation method with and without humidification in asthmatic mechanically ventilated patients. Pulm Pharmacol Ther 45:40–46

    Article  CAS  PubMed  Google Scholar 

  37. Moustafa IO et al (2017) Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients. Heart Lung 46(6):464–467

    Article  PubMed  Google Scholar 

  38. Ali AMA, Abdelrahim MEA (2014) Modeling and optimization of terbutaline emitted from a dry powder inhaler and influence on systemic bioavailability using data mining technology. J Pharm Innov 9(1):38–47

    Article  Google Scholar 

  39. Abdelrahim M, Assi KH, Chrystyn H (2013) Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow. Pharm Dev Technol 18(4):944–949

    Article  CAS  PubMed  Google Scholar 

  40. Elgendy MO, Abdelrahim ME, Eldin RS (2015) Potential benefit of repeated MDI inhalation technique counselling for patients with asthma. Eur J Hosp Pharm 22(6):318–322

    Article  Google Scholar 

  41. Szymusik I et al (2019) Perinatal outcome of in vitro fertilization singletons—10 years’ experience of one center. Arch Med Sci 15(3):666–672

    Article  PubMed  PubMed Central  Google Scholar 

  42. Li Y et al (2020) Pregnancy-associated plasma protein A as a predictor of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a meta-analysis of prospective studies. Arch Med Sci 16(1):8–15

    Article  CAS  PubMed  Google Scholar 

  43. Fijałkowska A et al (2018) Pregnancy as a predictor of deviations from the recommended diagnostic pathway in women with suspected pulmonary embolism: ZATPOL registry data. Arch Med Sci 14(4):838–845

    PubMed  Google Scholar 

  44. Hao Y et al (2021) Effects of n-3 polyunsaturated fatty acid supplementation on pregnancy outcomes: a systematic review and meta-analysis. Arch Med Sci. https://doi.org/10.5114/aoms/141577

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors have not disclosed any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lingli Li.

Ethics declarations

Conflict of interest

The authors have not disclosed any competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, L., Liu, L. & Xu, Y. Hypertension in pregnancy as a risk factor for placenta accreta spectrum: a systematic review incorporating a network meta-analysis. Arch Gynecol Obstet 307, 1323–1329 (2023). https://doi.org/10.1007/s00404-022-06551-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-022-06551-y

Keywords

Navigation